Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Sleep experts urge adoption of permanent standard time to protect public health as Americans prepare to ‘spring forward’

February 9, 2026

Media Advisory: Wear Red Canada highlights heart disease crisis facing Canadian women

February 9, 2026

First Intervention Shown to Lower Alzheimer’s and Dementia Incidence

February 9, 2026

Emerita Intersects 9.2m Grading 1.4% Copper, 0.4% Lead, 1.3% Zinc, 0.41 g/t Gold and 21.48 g/t Silver at El Cura

February 9, 2026

Mutuum Finance (MUTM) Reveals the Finalized V1 Protocol as Roadmap Phase 2 Unfolds

February 9, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Medical Aesthetic Devices Market Projected to Reach $37.9 Billion by 2029
Press Release

Medical Aesthetic Devices Market Projected to Reach $37.9 Billion by 2029

By News RoomDecember 9, 20253 Mins Read
Medical Aesthetic Devices Market Projected to Reach .9 Billion by 2029
Share
Facebook Twitter LinkedIn Pinterest Email
Medical Aesthetic Devices Market Projected to Reach .9 Billion by 2029

Dublin, Dec. 09, 2025 (GLOBE NEWSWIRE) — The “Medical Aesthetic Devices: Technologies and Global Markets” has been added to ResearchAndMarkets.com’s offering.
The global market for medical aesthetic devices continues its robust expansion, with a valuation of $20.1 billion in 2023. Projections indicate a growth trajectory to $37.9 billion by the end of 2029, reflecting a compound annual growth rate (CAGR) of 11.3% from 2024 onwards. Key drivers of this growth include the rising popularity of minimally invasive devices, a surge in the number of aesthetic procedures, advancements in cosmetic surgery technologies like lasers, increased medical tourism, a spike in demand for breast augmentation surgeries, and a growing prevalence of obesity.

Despite the optimistic outlook, several challenges could impede market progression. High procedural costs, inadequate reimbursement frameworks, stringent governmental regulations, societal and ethical concerns, and potential adverse effects pose significant hurdles over the coming years.

The market segmentation focuses on device type, application, end user, and geographical region. Notably, non-energy-based aesthetic devices held a larger market share in 2023, with an expected CAGR of 11.6% during the forecast period. These devices are favored due to their safety, minimal risk, and affordability.

Facial aesthetic procedures dominated the application segment in 2023, driven by the increasing popularity of treatments like Botox, dermal fillers, and skin resurfacing, appealing to both younger demographics and aging populations.

Hospitals represented the primary end-user segment in 2023. Regionally, North America comprised 36.7% of the market share, attributed to widespread adoption of medical aesthetics and the substantial presence of key manufacturers.

Prominent players in the global market include Alma Lasers, Johnson & Johnson Services Inc., El. En. S.p.A., Bausch Health Companies Inc., and Allergan Aesthetics, part of AbbVie.

Report Scope

This comprehensive report dissects the market for medical aesthetic devices, analyzing trends, challenges, and opportunities, and providing forecasts through 2029. It highlights emerging technologies and recent advancements, evaluates the financial health, product offerings, and strategic initiatives of leading companies.

  • North America: U.S., Canada, and Mexico.
  • Europe: Germany, U.K., France, Italy, Spain, and the Rest of Europe.
  • Asia-Pacific: China, Japan, India, South Korea, Australia, and the Rest of Asia-Pacific.

Historical data spans 2021 and 2022, with 2023 as the base year, extending forecasts to 2029.

Detailed Report Includes:

  • 65 data tables and 47 additional tables
  • An in-depth analysis of global trends from 2021-2023, estimates for 2024, and CAGR projections through 2029
  • COVID-19 implications and statistics for surgical procedures
  • Technological breakthroughs in laser treatments and the impact of cosmetic surgery on medical tourism
  • Insights into regulatory frameworks within the U.S. and Europe
  • Review of patents and research publications in medical aesthetic innovations
  • Discussion on industry ESG challenges and opportunities
  • Profiles of leading companies like Alma Lasers, Johnson & Johnson Services Inc., AbbVie Inc., Bausch Health Companies Inc., and El.En. S.p.A.

Key Attributes:

Report Attribute Details
No. of Pages 144
Forecast Period 2024 – 2029
Estimated Market Value (USD) in 2024 $22.2 Billion
Forecasted Market Value (USD) by 2029 $37.9 Billion
Compound Annual Growth Rate 11.3%
Regions Covered Global

Companies Featured

  • AbbVie Inc.
  • Alma Lasers
  • Bausch Health Companies Inc.
  • Candela Corp.
  • Cutera Inc.
  • Cynosure Lutronic
  • El.En. S.p.A.
  • Implantech
  • Johnson & Johnson Services Inc.
  • Lumenis be Ltd.
  • Medytox
  • Merz Pharma
  • Photomedex
  • Tiger Biosciences
  • Venus Concept

For more information about this report visit https://www.researchandmarkets.com/r/lbsmm2

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

  • Medical Aesthetic Devices Market

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Sleep experts urge adoption of permanent standard time to protect public health as Americans prepare to ‘spring forward’

Media Advisory: Wear Red Canada highlights heart disease crisis facing Canadian women

First Intervention Shown to Lower Alzheimer’s and Dementia Incidence

Emerita Intersects 9.2m Grading 1.4% Copper, 0.4% Lead, 1.3% Zinc, 0.41 g/t Gold and 21.48 g/t Silver at El Cura

Mutuum Finance (MUTM) Reveals the Finalized V1 Protocol as Roadmap Phase 2 Unfolds

Freehand Debuts as New Company with Dedicated AI Teams for Supply Chain Spend Management

Skyriss Securities Expands Platform Capabilities and Support Operations Across Key International Markets

dsm-firmenich provides preliminary comparative figures following the announced divestment of Animal Nutrition & Health (ANH)

Bitget Brings Blockchain4Youth to the LALIGA Youth Tournament in Thailand

Editors Picks

Media Advisory: Wear Red Canada highlights heart disease crisis facing Canadian women

February 9, 2026

First Intervention Shown to Lower Alzheimer’s and Dementia Incidence

February 9, 2026

Emerita Intersects 9.2m Grading 1.4% Copper, 0.4% Lead, 1.3% Zinc, 0.41 g/t Gold and 21.48 g/t Silver at El Cura

February 9, 2026

Mutuum Finance (MUTM) Reveals the Finalized V1 Protocol as Roadmap Phase 2 Unfolds

February 9, 2026

Subscribe to News

Get the latest Canada news and updates directly to your inbox.

Latest News

Freehand Debuts as New Company with Dedicated AI Teams for Supply Chain Spend Management

February 9, 2026

Skyriss Securities Expands Platform Capabilities and Support Operations Across Key International Markets

February 9, 2026

Halfpipe coach Trennon Paynter loves adventure

February 9, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version